Clinical Trial Update: Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating azimilide for atrial fibrillation has completed. The update reports on its efficacy and safety in these patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Azimilide (azimilide)

Snippet

Sponsor: Forest Laboratories | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED